EU_Infect_Contents.qxp 5/2/09 12:24 pm Page 8
Contents
Further Advances in the Treatment of Methicillin-resistant
Staphylococcus aureus 87
Richard P Wenzel,
1
Gonzalo Bearman
2
and Michael B Edmond
3
1. Professor and Chairman; 2. Associate Professor; 3. Professor of Internal Medicine,
Epidemiology and Community Health, Medical College of Virginia Hospitals,
Virginia Commonwealth University
Methicillin-resistant Staphylococcus aureus in Cystic Fibrosis 90
Giovanni Taccetti,
1
Silvia Campana,
1
Priscilla Cocchi,
1
Anna Silvia Neri,
1
Francesca Trevisan,
1
Vanessa Boni,
1
Cesare Braggion
1
and Filippo Festini
2
1. Cystic Fibrosis Centre, Meyer Hospital, Florence; 2. Department of Paediatrics,
University of Florence
Acinetobacter baumannii – Basic and Emerging
Mechanisms of Resistance 94
Patrice Nordmann
1
and Laurent Poirel
2
1. Professor of Medical Microbiology, University of South Paris;
2. Associate Researcher, French National Institute for Health, and
Medical Researcher, Department of Microbiology, Bicêtre Hospital
Parasitic Infections
Twenty Years of the Presence of Aedes albopictus
in Italy – From the Annoying Pest Mosquito to the
Real Disease Vector 98
Roberto Romi, Luciano Toma, Francesco Severini and Marco Di Luca
Department of Infectious, Parasitic and Immuno-mediated Diseases, Istituto Superiore di Sanità,
National Health Institute of Italy
Advances in the Management of Malaria – Making Antimalarial
Medicines Available to All Patients 102
Awa Marie Coll-Seck, Jan Van Erps and Katya Halil
Roll Back Malaria Partnership
Infection Control and Prevention
Prevention and Control of Infectious Disease Epidemics
within Europe 106
Dominique Legros,
1
Denis Coulombier,
2
Roberta Andraghetti,
1
Nedret Emiroglu,
1
Guénaël Rodier
1
and David L Heymann
1
1. World Health Organization (WHO); 2. European Centre for Disease Prevention and Control (ECDC)
Infection Control Experts Debate the Advances in Antisepsis and
How They Will Benefit Patients 108
Dinah Gould
Professor of Applied Health, City University, London
Preventing and Controlling the Risk of Post-operative
Surgical-site Infections 110
Hilary Humphreys
Professor of Clinical Microbiology, Royal Collage of Surgeons, Ireland
8 EUROPEAN INFECTIOUS DISEASE
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116